Abstract
Aortic valve disease is the most common cardiac valve condition in developed countries, and its prevalence increases with patient age, especially due to calcified aortic stenosis [24]. Although aortic valve replacement (AVR) remains the most effective treatment in the majority of cases for significant aortic stenosis as well as aortic regurgitation, few data are available for long-term surgical outcome. Perimount pericardial valves offer excellent hemodynamic function, and the present authors’ 10 year experience proved to be satisfactory when these valves were implanted in both the aortic and mitral positions [2, 3]. However, the long-term durability and performance of the valve remained questionable. The study aim was to evaluate long-term results of valve replacement for significant aortic valve disease, and long-term behavior of the aortic Perimount pericardial bioprosthesis, which the present authors have been implanting since 1984.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonini Canterin F, Zuppiroli A, Bogdan A et al (2003) Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 92:1479–1482
Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA (1996) The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg 61:615–620
Aupart MR, Neville PH, Hammami S, Sirinelli AL, Meurisse YA, Marchand MA (1997) Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg 113:492–498
Banbury MK, Cosgrove DM, White JA, Blackstone EH, Frater RW, Okies JE (2001) Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 72:753–757
Bergoend E, Aupart M, Kendja F, Sirinelli A, Neville P, Marchand M (2004) Twelve years’ experience with Carbomedics bileaflet valves. Arch Mal Coeur Vaiss 97: 214–220
Bonow RO, Carabello B, Chattergee K et al (1998) Guidelines for the management of patient with valvular heart disease. Circulation 98:1949–1984
Bortolotti U, Milano A, Thiene G et al (1987) Early mechanical failures of the Hancock pericardial xenograft. J Thorac Cardiovasc Surg 94:200–207
Chaput M, Bouchard D, Demers P et al (2005) Conversion to sinus rhythm do not improve long term survival after valve surgery: insight from a 20 year follow up study. Eur J Cardiothorac Surg 28:206–210
Dalrymple-Hay MJ, Crook T, Bannon PG et al (2002) Risk of reoperation for structural failure of aortic and mitral tissue valves. J Heart Valve Dis 11:419–423
Edmunds LH Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD (1996) Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 112:708–711
Gao G, Wu Y, Grunkemeier GL, Furnary AP, Starr A (2004) Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol 44:384–388
Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36:1152–1158
Hanania G, Michel PL, Montely JM et al (2004) The long term (15 years) evolution after valvular replacement with mechanical prosthesis or bioprosthesis between the age of 60 and 70 years. Arch Mal Coeur Vaiss 97:7–14
Ikonomidis JS, Kratz JM, Crumbley AJ et al (2003) Twenty year experience with the St. Jude Medical mechanical prosthesis. J Thorac Cardiovasc Surg 126:2022–2031
Iung B, Gohlke-Barwolf C, Tornos P et al (2002) Recommendations on the management of the asymptomatic patients with valvular heart disease. Eur Heart J 23:1253–1266
Jamieson WR, Burr LH, Munro AI, Miyagishima RT (1998) Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg 66(6 Suppl):S40–S43
Jamieson WR, Marchand MA, Pelletier CL et al (1999) Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and Perimount pericardial bioprostheses. J Thorac Cardiovasc Surg 118:297–304
Jamieson WR, Burr LH, Miyagishima RT et al (2003) Reoperation for bioprosthetic aortic structural failure: risk assessment. Eur J Cardiothorac Surg 24:873–878
Karni A, Holtzman R, Bass T et al (2001) Traumatic head injury in the anticoagulated patient: a lethal combination. Am Surg 67:1098–1100
Khan SS, Trento A, DeRobertis M et al (2001) Twenty year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 122:257–269
Kirsh M, Nakashima K, Kubota S, Houel R, Hillion ML, Loisance D (2004) The risk of reoperative heart valve procedures in octogenarian patients. J Heart Valve Dis 13:991–996
Lund O, Nielsen SL, Arildsen H, Ilkjaer LB, Pilegaaard HK (2000) Standard aortic St. Jude at 18 years: performance profile and determinants of outcome. Ann Thorac Surg 69:1459–1465
O’Brien KD (2005) Converting enzyme inhibitor and aortic calcification. Arch Intern Med 165:858–862
Otto CM (1998) Aortic stenosis. Clinical evaluation and optimal timing of surgery. Cardiol Clin 16:353–373
Potter DD, Sundt TM, Zehr KJ et al (2005) Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg 129:94–103
Rizzoli G, Bottio T, Thiene G, Toscano G, Casarotto D (2003) Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg 126:66–74
Rosand J, Eckman MH, Knudsen KA, Singer DE, Greesberg SM (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral haemorrhage. Arch Intern Med 164:880–884
Sidhu P, O’Kane H, Ali N et al (2001) Mechanical or bioprosthetic valves in the elderly: a 20-year comparison. Ann Thorac Surg 71(5 Suppl.):S257–S260
Sjalander A, Engstrom G, Berntrop E, Svensson P (2003) Risk of hemorrhagic stroke in patient with oral anticoagulation compared with the general population. J Intern Med 254:434–438
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bergoënd, E. et al. (2010). 20 years’ durability of Carpentier-Edwards Perimount stented pericardial aortic valve. In: Yankah, C.A., Weng, Y., Hetzer, R. (eds) Aortic Root Surgery. Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_31
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1869-8_31
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1868-1
Online ISBN: 978-3-7985-1869-8
eBook Packages: MedicineMedicine (R0)